Form 8-K - Current report:
SEC Accession No. 0001193125-22-211393
Filing Date
2022-08-03
Accepted
2022-08-03 17:21:08
Documents
14
Period of Report
2022-08-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d359483d8k.htm   iXBRL 8-K 26479
2 EX-5.1 d359483dex51.htm EX-5.1 6620
6 GRAPHIC g359483dsp5.jpg GRAPHIC 3976
  Complete submission text file 0001193125-22-211393.txt   162851

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA evh-20220803.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE evh-20220803_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evh-20220803_pre.xml EX-101.PRE 11273
8 EXTRACTED XBRL INSTANCE DOCUMENT d359483d8k_htm.xml XML 3356
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 221133708
SIC: 8741 Services-Management Services